Get paper from

journal cover

Demonstration of tumor inhibiting properties of a strongly immunostimulating low-molecular weight substance. Comparative studies with ifosfamide on the immuno-labile DS carcinosarcoma. Stimulation of the autoimmune activity for approx. 20 days by BA 1, a N-(2-cyanoethylene)-urea. Novel prophylactic possibilities

Arzneimittel-Forschung

Sep 1, 1975

M Ardenne, P G Reitnauer

PMID: 22

Get paper from

Abstract

A report is given on the recent discovery of outstanding immunological properties in BA 1 [N-(2-cyanoethylene)-urea] having a (low) molecular mass M = 111.104. Experiments in 214 DS carcinosarcoma bearing Wistar rats have shown that BA 1, at a dosage of only about 12 percent LD50 (150 m...read more

Mentioned in this Paper

Therapeutic Immunosuppression
Drug Tolerance
Immunologic Deficiency Syndromes
Antineoplastic Agents
N-(2-cyanoethylene)urea
Cyclophosphamide
Differential White Blood Cell Count Procedure
Metazoa
Specimen Type - Lymphocytes
Urea
13
3
5
19
7
Paper Details
References
    • References
    • Citations

      References currently unavailable

      We're still populating references for this paper, please check back later.
    • References
    • Citations

      No citations available

      This paper may not have been cited yet.
  • Demonstration of tumor inhibiting properties of a strongly immunostimulating low-molecular weight substance. Comparative studies with ifosfamide on the immuno-labile DS carcinosarcoma. Stimulation of the autoimmune activity for approx. 20 days by BA 1, a N-(2-cyanoethylene)-urea. Novel prophylactic possibilities

    Arzneimittel-Forschung

    Sep 1, 1975

    M Ardenne, P G Reitnauer

    PMID: 22

    DOI:

    Abstract

    A report is given on the recent discovery of outstanding immunological properties in BA 1 [N-(2-cyanoethylene)-urea] having a (low) molecular mass M = 111.104. Experiments in 214 DS carcinosarcoma bearing Wistar rats have shown that BA 1, at a dosage of only about 12 percent LD50 (150 m...read more

    Mentioned in this Paper

    Therapeutic Immunosuppression
    Drug Tolerance
    Immunologic Deficiency Syndromes
    Antineoplastic Agents
    N-(2-cyanoethylene)urea
    13
    3
    5
    19
    7

    Related Papers

    Paper Details
    References
    • References
    • Citations

      References currently unavailable

      We're still populating references for this paper, please check back later.
    • References
    • Citations

      No citations available

      This paper may not have been cited yet.
  • Get paper from

    © 2019 Meta ULC. All rights reserved.
    /papers/demonstration-of-tumor-inhibiting-properties-of-a/22